15^th World Congress on Biotechnology and Biotech Industries Meet March 20-21, 2017 Rome, Italy

George Perry is a Dean and Professor in the University of Texas

Biotechnology

Rob Krams is Chair and Professor of Molecular Bioengineering at Imperial College London. Prof Krams is trained as a medic and received his BSc (1987) and PhD (1990) degrees from the University of Amsterdam. His interest is in mechanobiology of blood vessels and he uses a combination of imaging, genomics and computational methods to elucidate genomic network information from endothelial cells. A new interest is in high throughput technologies. After a period of postdoctoral training in John Hopkins (Baltimore, USA), he moved to the world-renowned Thorax center (Rotterdam, NL) where he developed his skills in mechanobiology and imaging. From 2004-2008 he was a recipient of an established investigatorship of the Dutch Heart Foundation. He joined Imperial College in 2007.

Atherosclerosis, develops at predilection sites that are associated with changes in the blood velocity pattern. Endothelial cells are sensors for mechanical forces and mechanobiology has emerged as a new field of research, touching area’s as immunology, stem cell research, hearing, touching and pain. To that end we develop new technologies to study cells in well defined mechanical environments where we specifically focus upon mechanosensitive signalling pathways. The newly developed technologies consist of a platform where techniques like high throughput systems, microfluidics, quantitative imaging and synthetic biology smoothly interact.

Born in Rome the 7/12/1949, 5 children, held the medical degree at the University of Rome “La Sapienza” with full honour. VC is specialist in Clinical of Infectious Diseases (University of Rome) and in Hygiene and Public Health (University of Pisa), and PhD in Immunology (Brunnel University, England). His doctorate and post-doc experience have been carried out at the Clinical Research Centre in Harrow (England). He has been Assistant in Microbiology, and Associate professor in Immunology at the University of Pisa. Since 2000 to now, VC is Full Professor of Immunology and Director of the UNESCO Chair in Biotechnology at the University of Rome Tor Vergata. VC has been also President (2007-2010) of the Board of the National Institute for Infectious Diseases “Lazzaro Spallanzani” in Rome, Italy. He is consultants for several agencies of the United Nations (UNESCO, UNDP, OMS) and is scientific coordinator of several European and international Projects. VC has been Scientific Director and member of the Board of the International Reference Centre for AIDS “Chantal Biya” in Yaoundé, Cameroon and President of the University Spinoff Eurobiopark (European Group of Biotechnology at the Tior Vergata Science Park). VC published over 260 scientific publications on peer-review journals (Nature, Journal of Immunology, Infection and Immunity, Journal of Infectious Diseases, Immunology, Clinical Experimental Immunology, A, IDS, AIDS and Human Retrovirus Journal, etc.) in the sector of Microbial Immunology and Infectious Diseases, with special focus on AIDS and Tuberculosis.

Immunology, Virology, Biotechnology

Lidietta Giorno is a membrane biotechnologist with a strong background in biological science, chemical technologies, and new materials. Her research experience includes membrane bioengineering, biocatalytic membrane reactors, integrated membrane systems for bioseparations and bioconversions, downstream processing based on molecular separation, membrane chirotechnology, and membrane emulsifiers. She has been involved in membrane science and engineering research and development for almost twenty years. She is Director of the Institute on Membrane Technology of the National Research Council of Italy, ITM-CNR, and is involved in research co-operations at the European and international levels. Dr. Giorno has worked abroad in the USA at Sepracor Inc., in 1992; in The Netherlands at ATO-DLO, in 1994; in France, at The University of Compiegne, in 1997 and 2000. She is Visiting Professor at Tianjin University of Science and Technology, China, since 2008. Lidietta Giorno is co-author of three books and some 70 peer-reviewed scientific papers in international journals. She is a member of the editorial boards and referee pools of scientific journals and research agencies, and she sits on the boards of several international committees and scientific societies. In addition, Dr. Giorno has served on the European Membrane Society Council for two mandates and is currently the President of the EMS Council and editor of the EMS Membrane Newsletter.

Biotechnology, Membrane Technology

Dr Lucijan Mohorovic attained his MD, and specializing in Obstetrics and Gynecology, from the School of Medicine of the University of Rijeka. His specialist education continued with postgraduate studies in social medicine and ecology, after which he completed his PhD Doctorate in Medicine with a thesis entitled: " THE INFUENCE OF COAL COMBUSTION PRODUCTS ON THE COURSE OF PREGNANCY AND ITS OUTCOME IN MICRO- REGIONAL CONDITIONS”. Rijeka 1991. For more than 20 years he has focused on the protection of a healthy environment, originating from medical praxis in obstetric and gynecological primary care and long-term empirical observation of, and scientific research into, coal burning products which are harmful to reproductive health in the airpolluted environment around a coal power plant. He was nominated by the Institute of Medicine of the US National Academies for the 2009 Rhoda and Bernard Sarnat International Prize in Mental Health. To facilitate development of novel drugs and lay the groundwork for a new research projects with the pharmaceutical and biotechnological industry, we underline the usefulness of developing nanotechnologies being pursued to produce pharmacologically efficacious reducing agent where the methemoglobin reductase is overwhelmed, and a valuable contribution to neurodegenerative disease prevention and novel therapy aimed at reducing pathological methemoglobin ferric iron (Fe3+) back to hemoglobin ferrous iron (Fe2+).

Biotechnology, Environmental Medicine